Taurus Vascular has developed a minimally-invasive, catheter-based technology that places a self-deploying stent to facilitate continuous drainage of endoleaks and depressurization of the aneurysmal sac following endovascular aneurysm repair (EVAR). This approach addresses the high incidence of endoleaks, which affect up to 50% of patients and can lead to significant healthcare costs and the need for repeat procedures.
Funding
Funding not disclosed
Founders
Product
Problem
Endovascular aneurysm repair (EVAR) is the standard of care for treating abdominal aortic aneurysms, but up to 50% of patients experience endoleaks, where blood leaks back into the aneurysm sac. These endoleaks can cause the aneurysm to continue growing and potentially rupture, leading to repeat procedures and significant healthcare costs.
Solution
Taurus Vascular offers a minimally-invasive, catheter-based technology designed to facilitate continuous drainage of endoleaks and depressurization of the aneurysmal sac following EVAR. The technology involves placing a self-deploying stent between the high-pressure aneurysm sac and a nearby low-pressure vein. This creates a pressure gradient that allows for the continuous drainage of endoleaks, aiming to improve procedure outcomes and reduce the need for reintervention. By addressing the root cause of endoleaks, Taurus Vascular seeks to improve long-term outcomes for patients undergoing EVAR.
Target Audience
The primary target audience includes vascular surgeons and interventional radiologists performing EVAR procedures, as well as hospitals and medical centers specializing in aortic aneurysm treatment.
Features
- Minimally-invasive, catheter-based delivery system
- Self-deploying stent for easy and precise placement
- Continuous drainage of endoleaks from the aneurysm sac
- Depressurization of the aneurysmal sac to reduce rupture risk